The Food and Drug Administration continually announces new single entity, combination and rebranded medications. The purpose of this presentation is to familiarize the participant with those non-opioid medications with an indication for the management of migraine that have gained FDA approval since 2018.
Learning Objectives:
Review the most recent three years of FDA approved non-opioid medications for pain
Recall the mechanism of action for each of these agents
Describe safe and effective use of these agents in a given patient population
.jpg "Thomas B. Gregory, Pharm.D., BCPS, FASPE photo")